Inhibitory effect of Ginkgo biloba extract on human platelet aggregation

Platelets

Volumn 10, Issue 5, 1999, Pages 298-305

  Dutta Roy, Asim K ^a   Gordon, Margaret J ^a   Kelly, Collete ^a   Hunter, Kirsty ^a   Crosbie, Lynn ^a   Knight Carpentar, Tamsin ^b   Williams, Brent C ^b  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Flavonoids; Gingko biloba extract; Human platelet aggregation; TxA2 synthesis

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA TOCOPHEROL; ANTITHROMBOCYTIC AGENT; APIGENIN; CATECHIN; COLLAGEN; CYCLIC AMP; FLAVONOID; GINKGO BILOBA EXTRACT; MORIN; MYRICETIN; QUERCETIN; THROMBOXANE A2;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEMBRANE FLUIDITY; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE MEMBRANE; THROMBOCYTE RICH PLASMA;

EID: 0032867163     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109975933     Document Type: Article

References (40)

1. Hamet P, Hidektasu S, Umeda F, Franks, DJ. Platelets and vascular smooth muscle: abnormalities of phosphodiesterase, aggregation, and cell growth in experimental and human diabetes. Metabolism 1983; 32: 124-30
2. Kroll MH, Schafer AI. Biochemical mechanism of platelet activation. Blood 1989; 74: 1181-95
3. Dutta-Roy AK. Insulin mediated processes in platelets, erythrocytes and monocytes/macrophages: effect of essential fatty acid metabolism. Prostaglandins Leukotrienes Essent Fatty Acids 1994; 51: 385-99
4. Hamberg M, Svensson J, Samuelsson B. A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975; 74: 2994-8
5. 1: the endogenous physiological regulator of platelet mediated blood coagulation. Prostaglandins Leukotrienes Essent Fatty Acids 1989; 35: 189-95
6. Furman MI, Grigoryev D, Bray PF, Dise KR, Goldschmidt-Clermont PJ. Platelet tyrosine kinase and fibrinogen receptor activation. Circ Res 1994; 75: 172-80
7. Dutta-Roy AK, Ray TK, Sinha AK. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets. Science 1986; 231: 385-9
8. Harker, LA, Fuster V. Pharmacology of platelet inhibitors. J Am Coll Cardiol 1986; 8: B21-32
9. 1/prostacyclin receptor of human blood platelets. J Biol Chem 1987; 262: 12685-91
10. 1/prostacyclin and insulin in human erythrocytes and platelets. Life Sci 1991; 49: 1129-39.
11. Yusuf S, Witties J, Friedman I. Overview of results of randomized clinical trials in heart disease, unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. J Am Med Assoc 1988; 260: 2259-63
12. Coller BS, Anderson K, Weisman HF. New anti-platelet agents: platelet GPIIb/GPIIIa antagonists. Thromb Haemost 1995; 74: 302-8
13. DeFeudis FV. Gingko biloba extract (Egb761) Pharmacological Activities and Clinical Applications. Paris: Elsevier, 1991
14. Kleijnen J, Knipschild P. Gingko biloba. Lancet 1992; 340: 1136-9
15. Marcocci L, Packer L, Droylefaix MT, Sekaki A, Gardesalbert M. Antioxidant action of Gingko biloba extract EGb-761. Methods Enzymol 1994; 234: 462-75
16. Yan, LJ, Droylefaix MT, Packer L. Gingko biloba extract (EGB761) protects human low density lipoproteins against oxidative modification mediated by copper. Biochem Biophys Res Commun 1995; 212: 360-6
17. Khalil A, Fortun A, Bonnefontraousselot D, Gardesalbert M, Lepage S, Delattre J, Droylefaix MT. Antioxidant effect of EGb761 towards superoxide free radical action on LDL J Chim Phys Phys-Chim Biol 1996; 93: 143-50
18. White, HL, Scates PW, Cooper BR. Extracts of Gingko biloba leaves inhibit monoamine oxidase. Life Sci 1996; 58: 1315-21
19. Pietri S, Sequin JR, d'Arbigny P. Drieu K, Culcasi M. Ginkgo biloba extract EGb 761 pretreatment limits free radical-induced oxidative stress in patients undergoing coronary by pass surgery. Cardiovasc Drugs Ther 1997; 11: 121-31
20. Braquet P, Etienne A, Toupee C, Burgeon RH, Left J, Varagaftig BB. BN52021 and related compounds; a new series of highly specific PAF-acether inhibitor BN 52021. Lancet 1985; 1: 1501
21. Stucker O, Pons C, Duverger JP, d'Arbigny P, Direu K. Effect of Gingko biloba extract (EGb 761) on in vitro induced, white-platelet, arterial-thrombosis formation. Adv Gingko biloba Extract Res 1994; 3: 27-30
22. Landolfi R, Mower RL, Steiner M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Biochem Pharmacol 1984; 33: 1525-30
23. Cook NC, Samman S. Flavonoids: chemistry, metabolism, cardio-protective effects, and dietary sources. J Nutr Biochem 1996; 7: 66-76
24. Dutta-Roy AK, Gordon MJ, Campbell FM, Crosbie L. Arachidonic acid uptake by human platelets is mediated by CD36. Platelets 1996; 7: 291-5
25. Harper JS, Brooker G. Femtomote sensitive radioimmunoassay for cyclic AMP and cyclic GMP after acetylation by acetic anhydride. J Nucleotide Res 1975; 1: 207-18
26. 1 binding sites in rabbit erythrocyte membranes. Eur J Biochem 1993; 213: 1167-73
27. Bellizzi MC, Dutta-Roy AK, Duthie GG, James WPT. Vitamin E binding activity of red blood cells in smokers. Free Radic Res 1996; 27: 105-12
28. Ross M. Determination of ascorbic acid and uric acid in plasma by high performance liquid chromatography. J Chromatogr B. 1994; 657: 197-200
29. Beretz A, Cazenave JP. Old and new natural products as the source of modern anti-thrombotic drugs. Planta Med 1991; 57: S68-72
30. Dutta-Roy AK. α-Tocopherol-binding proteins: purification and characterization. Methods Enzymol 1997; 282: 278-97
31. 1. Biochem Pharmacol 1983; 32: 2813-7
32. Beretz A, Cazenave J-P, Anton R. Inhibition of aggregation and secretion of human platelets by querecetin and other flavonoids: structure-activity relationships. Agents Actions 1982; 12: 382-7
33. Mower R, Landolfi R, Steiner M. Inhibition in vitro platelet aggregation and arachidonic acid metabolism by flavone. Biochem Pharmacol 1984; 33: 357-63
34. Salvemini D, Denucci G, Gyglewski RJ, Vane JR. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc Natl Acad Sci USA 1989; 86; 6328-32
35. Duke MV, Salin, ML. Purification and characterization of an iron-containing superoxide dismutase from eucaryote, Gingko biloba. Arch Biochem Biophys 1985; 243: 305-14
36. Etienne A, Baroggi N. Effects of ginkgoglides on PAF-induced calcium mobilization in platelets. in: Braquet P, ed. Gingkoglides, Chemistry, Biology, Pharmacology and Clinical perspectives. S.A., J.R. Prous Science Publishers, 1988; 115-25
37. Stucker O, Pons C, Duverger JP, Driev K. Effects of Gingko biloba extract (EGB-761) on arteriolar spasm in a rat cremaster muscle preparation. Int J Microcirc Clin Exp 1996; 16: 98-104
38. Belougne E, Agvcjouf O, Imault P, Ovalaane FA, Doutremepuich F. Experimental thrombosis model induced by laser beam: application of aspirin and an extract of Gingko biloba, EGb 761. Thromb Res 1996; 82: 453-58
39. Schror K. Anti-platelet drugs: a comparative review. Drugs 1995; 50: 7-28
40. Roehm E. Low dose of aspirin inhibits arachidonic acid-precipitated platelet aggregation but not collagen-precipitated platelet aggregation. Am J Cardiol 1995; 76: 637-8